Skip to main content
. 2012 Oct 2;184(14):E751–E757. doi: 10.1503/cmaj.120430

Table 1:

Characteristics at enrolment of 185 patients with clinically diagnosed, uncomplicated acute rhinosinusitis

Characteristic Group; % (no.) of patients*
Prednisolone
n = 93
Placebo
n = 92
Age, yr, mean (SD) 43.9 (13.6) 42.4 (13.7)
Sex, female 67.7 (63/93) 55.4 (51/92)
Smoking history
 Never 38.2 (34/89) 41.6 (37/89)
 Former 33.7 (30/89) 39.3 (35/89)
 Current 28.1 (25/89) 19.1 (17/89)
Medical history
 Recent history of rhinosinusitis 32.6 (30/92) 32.2 (29/90)
 Asthma 6.5 (6/92) 8.9 (8/90)
 Seasonal allergic rhinitis 19.6 (18/92) 18.0 (16/89)
 Eczema 6.5 (6/92) 8.9 (8/90)
 Chronic obstructive pulmonary disease 1.1 (1/92) 1.1 (1/89)
Duration of symptoms, d, median (IQR) 12 (7–20) 13.5 (7–21)
Initial temperature, °C, median (IQR) 36.7 (36.3–37.0) 36.7 (36.3–37.0)
Pus on inspection 20.4 (19/93) 20.9 (19/91)
Postnasal drip on inspection 19.3 (17/88) 16.7 (15/90)
Nasal congestion 83.9 (78/93) 84.8 (78/92)
Facial pain or pressure 95.7 (89/93) 95.7 (88/92)
 Unilateral 36.5 (27/74) 39.5 (30/76)
 Bilateral 63.5 (47/74) 60.5 (46/76)
Severity of facial pain, score, mean (SD) 3.0 (1.3) 3.1 (1.4)
Severity of problem according to physician
 Mild problem 28.0 (26/93) 30.3 (27/89)
 Moderate problem 67.7 (63/93) 68.5 (61/89)
 Severe problem 4.3 (4/93) 1.1 (1/89)
Laboratory measurement
 Positive result of Phadiatop test (atopic status) 35.4 (29/82) 27.3 (21/77)

Note: IQR = interquartile range, SD = standard deviation.

*

Unless stated otherwise.

Consultation with physician because of rhinosinusitis in the 3 years before the study.

Score assigned by patient (0 = no problem, 1 = very mild problem, 2 = mild problem, 3 = moderate problem, 4 = severe problem, 5 = problem as bad as it can be).